Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alzheimer's Disease (Incl Subtypes): early-phase trial registry
3 of 5 indexed Alzheimer's Disease (Incl Subtypes) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Alzheimer's Disease (Incl Subtypes): 5 US clinical trials tracked, 3 recruiting.
Alzheimer's Disease (Incl Subtypes) is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts Institute of Technology, running 1 of these trials.
Enrollment posture brief
Registry condition alzheimers-disease-incl-subtypes
OPEN 3 | RECR 60% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Alzheimer's Disease (Incl Subtypes) lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alzheimer's Disease (Incl Subtypes) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alzheimer's Disease (Incl Subtypes) is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Alzheimer's Disease (Incl Subtypes) research.
Massachusetts Institute of Technology accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Alzheimer's Disease (Incl Subtypes) trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Alzheimer's Disease (Incl Subtypes) research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Improving PCP Advance Care Planning for People With ADRD
University of Pittsburgh
NCT06565169
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Indiana University
NCT05643144
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
Massachusetts Institute of Technology
NCT05655195
Sirtuin-NAD Activator in Alzheimer's Disease
Brigham and Women's Hospital
NCT05040321
Vietnamese Caregiver Intervention Study
University of California, Davis
NCT03218982
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Alzheimer's Disease (Incl Subtypes) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alzheimer's Disease (Incl Subtypes) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alzheimer's Disease (Incl Subtypes) page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Alzheimer's Disease (Incl Subtypes) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts Institute of Technology sponsors the most Alzheimer's Disease (Incl Subtypes) trials on record, review their full trial history before evaluating a specific study. See Massachusetts Institute of Technology's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alzheimer's Disease (Incl Subtypes) condition card totals 5 registered trials; most-linked intervention Enhanced psycho-education about dementia and caregiving; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.